Literature DB >> 25068611

"Let's Move" campaign: applying the extended parallel process model.

Alicia Batchelder1, Jonathan Matusitz.   

Abstract

This article examines Michelle Obama's health campaign, "Let's Move," through the lens of the extended parallel process model (EPPM). "Let's Move" aims to reduce the childhood obesity epidemic in the United States. Developed by Kim Witte, EPPM rests on the premise that people's attitudes can be changed when fear is exploited as a factor of persuasion. Fear appeals work best (a) when a person feels a concern about the issue or situation, and (b) when he or she believes to have the capability of dealing with that issue or situation. Overall, the analysis found that "Let's Move" is based on past health campaigns that have been successful. An important element of the campaign is the use of fear appeals (as it is postulated by EPPM). For example, part of the campaign's strategies is to explain the severity of the diseases associated with obesity. By looking at the steps of EPPM, readers can also understand the strengths and weaknesses of "Let's Move."

Entities:  

Keywords:  Child obesity; communication; extended parallel process model; fear appeals; health

Mesh:

Year:  2014        PMID: 25068611     DOI: 10.1080/19371918.2013.865110

Source DB:  PubMed          Journal:  Soc Work Public Health        ISSN: 1937-190X


  2 in total

1.  Weight Status Change in Chinese American Children over a Ten-Year Period: Retrospective Study of a Primary Care Pediatric Population.

Authors:  Jia Lu Lilian Lin; Olivia Zhong; Raymond Tse; Jennifer D Lau; Eda Chao; Loretta Au
Journal:  Int J Environ Res Public Health       Date:  2022-05-13       Impact factor: 4.614

2.  An educational intervention based on the extended parallel process model to improve attitude, behavioral intention, and early breast cancer diagnosis: a randomized trial.

Authors:  Vahideh Termeh Zonouzy; Shamsaddin Niknami; Fazlollah Ghofranipour; Ali Montazeri
Journal:  Int J Womens Health       Date:  2018-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.